HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies.
dc.contributor.author | Fouda, GG | |
dc.contributor.author | Yates, NL | |
dc.contributor.author | Pollara, J | |
dc.contributor.author | Shen, X | |
dc.contributor.author | Overman, GR | |
dc.contributor.author | Mahlokozera, T | |
dc.contributor.author | Wilks, AB | |
dc.contributor.author | Kang, HH | |
dc.contributor.author | Salazar-Gonzalez, JF | |
dc.contributor.author | Salazar, MG | |
dc.contributor.author | Kalilani, L | |
dc.contributor.author | Meshnick, SR | |
dc.contributor.author | Hahn, BH | |
dc.contributor.author | Shaw, GM | |
dc.contributor.author | Lovingood, RV | |
dc.contributor.author | Denny, TN | |
dc.contributor.author | Haynes, B | |
dc.contributor.author | Letvin, NL | |
dc.contributor.author | Ferrari, G | |
dc.contributor.author | Montefiori, DC | |
dc.contributor.author | Tomaras, GD | |
dc.contributor.author | Permar, SR | |
dc.contributor.author | Immunology, the Center for HIVAIDS Vaccine | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2017-06-02T12:45:06Z | |
dc.date.available | 2017-06-02T12:45:06Z | |
dc.date.issued | 2011-09 | |
dc.description.abstract | Despite months of mucosal virus exposure, the majority of breastfed infants born to HIV-infected mothers do not become infected, raising the possibility that immune factors in milk inhibit mucosal transmission of HIV. HIV Envelope (Env)-specific antibodies are present in the milk of HIV-infected mothers, but little is known about their virus-specific functions. In this study, HIV Env-specific antibody binding, autologous and heterologous virus neutralization, and antibody-dependent cell cytotoxicity (ADCC) responses were measured in the milk and plasma of 41 HIV-infected lactating women. Although IgA is the predominant antibody isotype in milk, HIV Env-specific IgG responses were higher in magnitude than HIV Env-specific IgA responses in milk. The concentrations of anti-HIV gp120 IgG in milk and plasma were directly correlated (r = 0.75; P < 0.0001), yet the response in milk was 2 logarithm units lower than in plasma. Similarly, heterologous virus neutralization (r = 0.39; P = 0.010) and ADCC activity (r = 0.64; P < 0.0001) in milk were directly correlated with that in the systemic compartment but were 2 log units lower in magnitude. Autologous neutralization was rarely detected in milk. Milk heterologous virus neutralization titers correlated with HIV gp120 Env-binding IgG responses but not with IgA responses (r = 0.71 and P < 0.0001, and r = 0.17 and P = 0.30). Moreover, IgGs purified from milk and plasma had equal neutralizing potencies against a tier 1 virus (r = 0.65; P < 0.0001), whereas only 1 out of 35 tested non-IgG milk fractions had detectable neutralization. These results suggest that plasma-derived IgG antibodies mediate the majority of the low-level HIV neutralization and ADCC activity in breast milk. | |
dc.identifier | ||
dc.identifier | JVI.05174-11 | |
dc.identifier.eissn | 1098-5514 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | American Society for Microbiology | |
dc.relation.ispartof | J Virol | |
dc.relation.isversionof | 10.1128/JVI.05174-11 | |
dc.subject | Antibodies, Neutralizing | |
dc.subject | Antibody Formation | |
dc.subject | Antibody-Dependent Cell Cytotoxicity | |
dc.subject | Cross Reactions | |
dc.subject | Female | |
dc.subject | HIV Antibodies | |
dc.subject | HIV Infections | |
dc.subject | Humans | |
dc.subject | Immunoglobulin A | |
dc.subject | Immunoglobulin G | |
dc.subject | Milk, Human | |
dc.subject | Neutralization Tests | |
dc.subject | Plasma | |
dc.subject | env Gene Products, Human Immunodeficiency Virus | |
dc.title | HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies. | |
dc.type | Journal article | |
duke.contributor.orcid | Shen, X|0000-0001-8076-1931|0000-0002-8387-3952 | |
duke.contributor.orcid | Ferrari, G|0000-0001-7747-3349 | |
duke.contributor.orcid | Montefiori, DC|0000-0003-0856-6319 | |
duke.contributor.orcid | Tomaras, GD|0000-0001-8076-1931 | |
pubs.author-url | ||
pubs.begin-page | 9555 | |
pubs.end-page | 9567 | |
pubs.issue | 18 | |
pubs.organisational-group | Basic Science Departments | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Duke | |
pubs.organisational-group | Duke Cancer Institute | |
pubs.organisational-group | Duke Human Vaccine Institute | |
pubs.organisational-group | Immunology | |
pubs.organisational-group | Institutes and Centers | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Medicine, Duke Human Vaccine Institute | |
pubs.organisational-group | Molecular Genetics and Microbiology | |
pubs.organisational-group | Pediatrics | |
pubs.organisational-group | Pediatrics, Infectious Diseases | |
pubs.organisational-group | School of Medicine | |
pubs.organisational-group | Surgery | |
pubs.organisational-group | Surgery, Surgical Sciences | |
pubs.publication-status | Published | |
pubs.volume | 85 |